These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 31109206)
1. Effect of Fenofibrate on the Expression of Inflammatory Mediators in a Diabetic Rat Model. Yeh PT; Wang LC; Chang SW; Yang WS; Yang CM; Yang CH Curr Eye Res; 2019 Oct; 44(10):1121-1132. PubMed ID: 31109206 [No Abstract] [Full Text] [Related]
2. Cilostazol Attenuates Retinal Oxidative Stress and Inflammation in a Streptozotocin-Induced Diabetic Animal Model. Yeh PT; Huang YH; Chang SW; Wang LC; Yang CM; Yang WS; Lin CW; Yang CH Curr Eye Res; 2019 Mar; 44(3):294-302. PubMed ID: 30373407 [TBL] [Abstract][Full Text] [Related]
3. Astaxanthin Inhibits Expression of Retinal Oxidative Stress and Inflammatory Mediators in Streptozotocin-Induced Diabetic Rats. Yeh PT; Huang HW; Yang CM; Yang WS; Yang CH PLoS One; 2016; 11(1):e0146438. PubMed ID: 26765843 [TBL] [Abstract][Full Text] [Related]
4. Effect of fenofibrate on diabetic retinopathy in rats via SIRT1/NF-κB signaling pathway. Chen N; Jiang K; Yan GG Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8630-8636. PubMed ID: 31646597 [TBL] [Abstract][Full Text] [Related]
5. Fenofibrate Ameliorates Oxidative Stress-Induced Retinal Microvascular Dysfunction in Diabetic Rats. Li J; Wang P; Chen Z; Yu S; Xu H Curr Eye Res; 2018 Nov; 43(11):1395-1403. PubMed ID: 30024319 [TBL] [Abstract][Full Text] [Related]
6. Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation. Liu Q; Zhang F; Zhang X; Cheng R; Ma JX; Yi J; Li J Mol Cell Biochem; 2018 Aug; 445(1-2):105-115. PubMed ID: 29264825 [TBL] [Abstract][Full Text] [Related]
7. Retinal not systemic oxidative and inflammatory stress correlated with VEGF expression in rodent models of insulin resistance and diabetes. Mima A; Qi W; Hiraoka-Yamomoto J; Park K; Matsumoto M; Kitada M; Li Q; Mizutani K; Yu E; Shimada T; Lee J; Shoelson SE; Jobin C; Rask-Madsen C; King GL Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8424-32. PubMed ID: 23197686 [TBL] [Abstract][Full Text] [Related]
8. Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants. Kowluru RA; Odenbach S Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4161-6. PubMed ID: 15505070 [TBL] [Abstract][Full Text] [Related]
9. Effects of fenofibrate on adiponectin expression in retinas of streptozotocin-induced diabetic rats. Hsu YJ; Wang LC; Yang WS; Yang CM; Yang CH J Diabetes Res; 2014; 2014():540326. PubMed ID: 25525608 [TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of docosahexanoic acid and lutein on retinal structural, metabolic, and functional abnormalities in diabetic rats. Arnal E; Miranda M; Johnsen-Soriano S; Alvarez-Nölting R; Díaz-Llopis M; Araiz J; Cervera E; Bosch-Morell F; Romero FJ Curr Eye Res; 2009 Nov; 34(11):928-38. PubMed ID: 19958109 [TBL] [Abstract][Full Text] [Related]
11. Involvement of advanced glycation end products, oxidative stress and nuclear factor-kappaB in the development of diabetic keratopathy. Kim J; Kim CS; Sohn E; Jeong IH; Kim H; Kim JS Graefes Arch Clin Exp Ophthalmol; 2011 Apr; 249(4):529-36. PubMed ID: 21104267 [TBL] [Abstract][Full Text] [Related]
12. UPP mediated Diabetic Retinopathy via ROS/PARP and NF-κB inflammatory factor pathways. Luo DW; Zheng Z; Wang H; Fan Y; Chen F; Sun Y; Wang WJ; Sun T; Xu X Curr Mol Med; 2015; 15(8):790-9. PubMed ID: 26391545 [TBL] [Abstract][Full Text] [Related]
13. Resolvin D1 inhibits inflammatory response in STZ-induced diabetic retinopathy rats: Possible involvement of NLRP3 inflammasome and NF-κB signaling pathway. Yin Y; Chen F; Wang W; Wang H; Zhang X Mol Vis; 2017; 23():242-250. PubMed ID: 28465656 [TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor α protects capillary pericytes in the retina. Ding L; Cheng R; Hu Y; Takahashi Y; Jenkins AJ; Keech AC; Humphries KM; Gu X; Elliott MH; Xia X; Ma JX Am J Pathol; 2014 Oct; 184(10):2709-20. PubMed ID: 25108226 [TBL] [Abstract][Full Text] [Related]
15. Hydrogen-rich saline prevents early neurovascular dysfunction resulting from inhibition of oxidative stress in STZ-diabetic rats. Feng Y; Wang R; Xu J; Sun J; Xu T; Gu Q; Wu X Curr Eye Res; 2013 Mar; 38(3):396-404. PubMed ID: 23252792 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models. Chen Y; Hu Y; Lin M; Jenkins AJ; Keech AC; Mott R; Lyons TJ; Ma JX Diabetes; 2013 Jan; 62(1):261-72. PubMed ID: 23043158 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy. Deng G; Moran EP; Cheng R; Matlock G; Zhou K; Moran D; Chen D; Yu Q; Ma JX Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5030-5042. PubMed ID: 28979999 [TBL] [Abstract][Full Text] [Related]
18. Fenofibrate improves renal function by amelioration of NOX-4, IL-18, and p53 expression in an experimental model of diabetic nephropathy. Yaribeygi H; Mohammadi MT; Rezaee R; Sahebkar A J Cell Biochem; 2018 Sep; 119(9):7458-7469. PubMed ID: 29761900 [TBL] [Abstract][Full Text] [Related]
19. HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo. Jiang S; Chen X Drug Des Devel Ther; 2017; 11():783-795. PubMed ID: 28352154 [TBL] [Abstract][Full Text] [Related]
20. Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-κB and transforming growth factor-β1/Smad3 in diabetic nephropathy. Li L; Emmett N; Mann D; Zhao X Exp Biol Med (Maywood); 2010 Mar; 235(3):383-91. PubMed ID: 20404057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]